Pharsight

1. Acanya patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5733886	BAUSCH	Compositions of clindamycin and benzoyl peroxide for acne treatment	Mar, 2015 (9 years ago)
US8895070	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US10220049	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US8663699	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US10624918	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US9078870	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US8288434	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Aug, 2029 (5 years from now)

Market Authorisation Date: 23 October, 2008

Treatment: Treatment of acne; Topical treatment of acne vulgaris in patients 12 years or older

Dosage: GEL;TOPICAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
1.2%/2.5%	20 Dec, 2012	1	19 Jun, 2015	05 Aug, 2029	Eligible
1.2%/3.75%	30 Sep, 2015	1	05 Jun, 2018	05 Aug, 2029	Eligible

Strength	Dosage	Availability
2.5%;EQ 1.2% BASE	GEL;TOPICAL	Prescription

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry	Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5466446	STIEFEL	Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof	Feb, 2014 (10 years ago)

Market Authorisation Date: 26 August, 2002

Treatment: NA

Dosage: GEL;TOPICAL

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
1% / 5%	11 Dec, 2008	1	26 Jun, 2012	14 Nov, 2012	Deferred

Strength	Dosage	Availability
5%;1.2%	GEL;TOPICAL	Prescription

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5733886	BAUSCH	Compositions of clindamycin and benzoyl peroxide for acne treatment	Mar, 2015 (9 years ago)
US10137142	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US10220049	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US9561208	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US9504704	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Jun, 2029 (5 years from now)
US8288434	BAUSCH	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent	Aug, 2029 (5 years from now)

Market Authorisation Date: 23 October, 2008

Treatment: Topical treatment of acne vulgaris in patients 12 years or older; Treatment of acne

Dosage: GEL;TOPICAL